Emergent says over-the-counter Narcan will be available by late summer

Emergent BioSolutions confirmed that the Food and Drug Administration approved Narcan HCI Nasal Spray as an over-the-counter emergency treatment of opioid overdose. Emergent anticipates Narcan will be available on U.S. shelves and at online retailers by the late summer "to account for manufacturing changes that will be implemented to support nonprescription packaging, as well as supply chain modifications." In the meantime, the prescription product will remain in readily available supply through current access channels, including pharmacies through standing order or co-prescription laws and through community distribution, the company said in a statement.